MindMaze Therapeutics Holding (RLFTF)

[dmsrz8]

Great to see!! Long duration though till Dec 2021...not sure that is ideal:


Study Type :
Interventional (Clinical Trial)

Estimated Enrollment :
80 participants

Allocation:
Randomized

Intervention Model:
Parallel Assignment

Intervention Model Description:
Patients will be randomly allocated to receive either Aviptadil together with standard care or the placebo (NaCl 0.9%) together with standard care,

Masking:
Double (Participant, Investigator)

Masking Description:
Patients and the investigator administering inhalation devices of drug or placebo are not aware of which group they have been randomized to (double-blinded). Someone not involved in the study (e.g. the hospital pharmacist or a nurse not involved in study) prepares the inhalation devices with either drug or placebo according to the randomization plan received by the CTU

Primary Purpose:
Treatment

Official Title:
Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS: a Randomized, Placebo Controlled, Multicenter Trial

Estimated Study Start Date :
September 2020

Estimated Primary Completion Date :
December 2021

Estimated Study Completion Date :
December 2021